Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BUY RDOC -- Ignore unavailable to you. Want to Upgrade?

To: Dennis who wrote (21)	5/8/1998 7:23:00 PM
From: Jasman	Read Replies (1) \| Respond to of 130

Dennis, great day for both RBOT and RDOC... I think the funds are looking at this sector very closely. I still think RDOC is extremely undervalued. RDOC has practically no debt and plenty of cash... a book value of close to $3 makes RDOC a safe choice in the biotech arena. Also the company is very well managed and very meticulous, as evidenced by 1) an appropriate ticker symbol RDOC, which is an abbreviation for its main product, RoboDoc. 2) Relocating to state of the art facilities in Davis, California and having enough wisdom to foresee the need fo increase space in the future and building accordingly... Can expand another 3000 square feet if needed! 3) Spending more money on marketing, sales and research to establish a first mover advantage (RDOC has no current competitors). 4) First establishing itself as the leader in programmable robots for knee and hip replacement surgeries in Germany and Austria, where such surgeries are more common. Sidenote: Management has a big stake in RDOC. One key executive even assigned RDOC as a beneficiary of a life insurance policy, which RDOC received $3 million. ONLY 400,000 shares as float... I also have a feeling that RDOC is going to have better than expected earnings for the upcoming quarter. I wouldn't be surprised if RDOC turns a profit. More and more people are discovering the value in these stocks. Short term target for RDOC raised to $10! Buy below $7. RBOT short term target $20!